BioCentury
ARTICLE | Clinical News

Recombinant human minibody against complement component C5 fused with RGD-motif regulatory update

November 24, 2008 8:00 AM UTC

EMEA's Committee for Orphan Medical Products (COMP) issued a positive opinion to grant Orphan Drug designation for Adienne's recombinant human minibody against complement component C5 fused with RGD-m...